The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Open accessAbstract
BACKGROUND: Cilazapril is a novel angiotensin converting enzyme inhibitor with antiproliferative effects in the rat model after balloon injury. METHODS AND RESULTS: We conducted a randomized, double-blind placebo-controlled trial to assess the effect of cilazapril in angiographic restenosis prevention after percutaneous transluminal coronary angioplasty (PTCA). Patients received cilazapril 2.5 mg in the evening after successful PTCA and 5 mg b.i.d. for 6 months or matched placebo. In addition, all patients received aspirin for 6 months. Coronary angiograms before PTCA, after PTCA, and at 6-month follow-up were quantitatively analyzed. In 94% of 735 recruited patients, PTCA was successful and all inclusion and exclusion criteria were met. For the per-protocol analysis, quantitative angiography after PTCA and at follow-up was available in 595 patients who complied with the treatment regimen (309 control, 286 cilazapril). The mean difference in minimal coronary lumen diameter between post-PTCA and follow-up angiogram (primary end point) was -0.29 +/- 0.49 mm in the control group and -0.27 +/- 0.51 mm in the cilazapril group. Clinical events during 6-month follow-up, analyzed on an intention-to-treat basis, were ranked according to the most serious clinical event ranging from death (control, two; cilazapril, three), nonfatal myocardial infarction (control, eight; cilazapril, 5), coronary revascularization (control, 51; cilazapril, 53), or recurrent angina requiring medical therapy (control, 67; cilazapril, 68) to none of the above (control, 224; cilazapril, 212). There were no significant differences in ranking. CONCLUSIONS: Long-term angiotensin converting enzyme inhibition with cilazapril in a dose of 5 mg b.i.d. does not prevent restenosis and does not favorably influence the overall clinical outcome after PTCA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Nonoperative Dilatation of Coronary-Artery Stenosis: Percutaneous Transluminal Coronary Angioplasty
Grüntzig, A. R., Senning, Å., & Siegenthaler, W. E. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907123010201 · Cited by 2,419
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Serruys, P. W., Luijten, H. E., Beatt, K. J., Geuskens, R., de Feyter, P. J., van den Brand, M., Reiber, J. H., ten Katen, H. J., van Es, G. A., & Hugenholtz, P. G. (1988) · Circulation · doi:10.1161/01.cir.77.2.361 · Cited by 931
Self-citationLiu, M. W., Roubin, G. S., & King, S. B. (1989) · Circulation · doi:10.1161/01.cir.79.6.1374 · Cited by 927
Nobuyoshi, M., Kimura, T., Nosaka, H., Mioka, S., Ueno, K., Yokoi, H., Hamasaki, N., Horiuchi, H., & Ohishi, H. (1988) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(88)80046-9 · Cited by 875
Percutaneous Transluminal Coronary Angioplasty in 1985–1986 and 1977–1981
Detre, K., Holubkov, R., Kelsey, S., Cowley, M., Kent, K., Williams, D., Myler, R., Faxon, D., Holmes, D., Bourassa, M., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802043180501 · Cited by 851
Angiographie morphology and the pathogenesis of unstable angina pectoris
Ambrose, J. A., Winters, S. L., Stern, A., Eng, A., Teichholz, L. E., Gorlin, R., & Fuster, V. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80384-3 · Cited by 801
Ip, J. H., Fuster, V., Badimon, L., Badimon, J., Taubman, M. B., & Chesebro, J. H. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92845-s · Cited by 765
Replication of smooth muscle cells in vascular disease.
Schwartz, S. M., Campbell, G. R., & Campbell, J. H. (1986) · Circulation Research · doi:10.1161/01.res.58.4.427 · Cited by 759
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
Daemen, M. J., Lombardi, D. M., Bosman, F. T., & Schwartz, S. M. (1991) · Circulation Research · doi:10.1161/01.res.68.2.450 · Cited by 737
Lindner, V, & Reidy, M. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3739 · Cited by 719
Schwartz, L., Bourassa, M. G., Lespérance, J., Aldridge, H. E., Kazim, F., Salvatori, V. A., Henderson, M., Bonan, R., & David, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182603 · Cited by 692
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.
Steele, P. M., Chesebro, J. H., Stanson, A. W., Holmes, D. R., Dewanjee, M. K., Badimon, L., & Fuster, V (1985) · Circulation Research · doi:10.1161/01.res.57.1.105 · Cited by 632
Naftilan, A. J., Pratt, R. E., & Dzau, V. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114032 · Cited by 623
Forrester, J. S., Fishbein, M., Helfant, R., & Fagin, J. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80196-2 · Cited by 557
Role of basic fibroblast growth factor in vascular lesion formation.
Lindner, V, Lappi, D. A., Baird, A., Majack, R. A., & Reidy, M. A. (1991) · Circulation Research · doi:10.1161/01.res.68.1.106 · Cited by 517
PDGF ligand and receptor gene expression during repair of arterial injury.
Majesky, M. W., Reidy, M. A., Bowen-Pope, D. F., Hart, C. E., Wilcox, J. N., & Schwartz, S. M. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.5.2149 · Cited by 430
Fingerle, J., Johnson, R., Clowes, A. W., Majesky, M. W., & Reidy, M. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8412 · Cited by 414
Barnathan, E. S., Schwartz, J. S., Taylor, L., Laskey, W. K., Kleaveland, J. P., Kussmaul, W. G., & Hirshfeld, J. W. (1987) · Circulation · doi:10.1161/01.cir.76.1.125 · Cited by 324
Hammacher, A., Hellman, U., Johnsson, A., Ostman, A., Gunnarsson, K., Westermark, B., Wasteson, A., & Heldin, C. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37619-1 · Cited by 309
Platelet accumulation in experimental angioplasty: time course and relation to vascular injury.
Wilentz, J. R., Sanborn, T. A., Haudenschild, C. C., Valeri, C. R., Ryan, T. J., & Faxon, D. P. (1987) · Circulation · doi:10.1161/01.cir.75.3.636 · Cited by 294
Christen, Y., Waeber, B., Nussberger, J., Porchet, M., Borland, R. M., Lee, R. J., Maggon, K., Shum, L., Timmermans, P. B., & Brunner, H. R. (1991) · Circulation · doi:10.1161/01.cir.83.4.1333 · Cited by 244
Owens, G. K. (1987) · Hypertension · doi:10.1161/01.hyp.9.2.178 · Cited by 227
Recurrence rate after successful coronary angioplasty
KALTENBACH, M., KOBER, G., SCHERER, D., & VALLBRACHT, C. (1985) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061852 · Cited by 178
Fleming, R. M., Kirkeeide, R. L., Smalling, R. W., Gould, K. L., & Stuart, Y. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90752-u · Cited by 177
Fingerle, J., Au, Y. P., Clowes, A. W., & Reidy, M. A. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.6.1082 · Cited by 172
Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat.
Owens, G. K., & Schwartz, S. M. (1983) · Circulation Research · doi:10.1161/01.res.53.4.491 · Cited by 163
Prevention of restenosis by lovastatin after successful coronary angioplasty
Sahni, R., Maniet, A. R., Voci, G., & Banka, V. S. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90002-y · Cited by 161
Rensing, B. J. W. M., Hermans, W. R. M., Deckers, J. W., de Feyter, P. J., Tijssen, J. G. P., & Serruys, P. W. J. C. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90274-q · Cited by 158
de Feyter, P. J., Suryapranata, H., Serruys, P. W. J. C., Beatt, K. J., van Domburg, R., van den Brand, M., Tijssen, J. G. P., Azar, A. J., & Hugenholtz, P. G. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90401-9 · Cited by 152
Hanson, S. R., Powell, J. S., Dodson, T. F., Lumsden, A. B., Kelly, A. B., Anderson, J., Clowes, A. W., & Harker, L. (1991) · Hypertension · doi:10.1161/01.hyp.18.4_suppl.ii70 · Cited by 136
Powell, J. S., Müller, R., Rouge, M., Kühn, H., Hefti, F., & Baumgartner, H. R. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199016004-00010 · Cited by 112
Cardiac Imaging: A Companion to Braunwald's Heart Disease
Stolberg, H. O. R. (1991) · Radiology · doi:10.1148/radiology.180.3.684 · Cited by 49
Induction of Thrombospondin Expression in Vascular Smooth Muscle Cells by Angiotensin II
Scott‐Burden, T., Resink, T. J., Hahn, A. W. A., & Bühler, F. R. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000167-00007 · Cited by 45
The metabolic syndrome and signal transduction of gene expression
Rupp, H. (1991) · Steinkopff eBooks · doi:10.1007/978-3-662-30769-4_7 · Cited by 29
Angiotensin converting enzyme inhibition reduces restenosis in experimental angioplasty
Bilazarian, S., Currier, J. W., Haudenschild, C. C., Heyman, D., Powell, J. R., Ryan, T. J., & Faxon, D. P. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)92040-s · Cited by 20
Cited by
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
The Intima: Soil for Atherosclerosis and Restenosis
Schwartz, S. M., deBlois, D., & O’Brien, E. R. M. (1995) · Circulation Research · doi:10.1161/01.res.77.3.445 · Cited by 971
Topol, E., Califf, R., Weisman, H., Ellis, S., Tcheng, J., Worley, S., Ivanhoe, R., George, B., Fintel, D., Weston, M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90007-8 · Cited by 838
Topol, E. J., Leya, F., Pinkerton, C. A., Whitlow, P. L., Hofling, B., Simonton, C. A., Masden, R. R., Serruys, P. W., Leon, M. B., Williams, D. O., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307223290401 · Cited by 698
Metadata
- Venue
- Circulation
- Published
- 1992-07
- Volume
- 86
- Issue
- 1
- Pages
- 100-110
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1815855529
- Cited by
- 539
- References
- 37
- FWCI
- 76.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.